Meeting
2023 ASCO Genitourinary Cancers Symposium
Outcomes of partial nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian multi-institutional collaborative.
Authors
Rahul K. Bansal
St Joseph Healthcare Hamilton, Hamilton, ON, Canada
Rahul K. Bansal , Raees Cassim , Ryan Sun , Ranjeeta Mallick , Antonio Finelli , Simon Tanguay , Darrel E Drachenberg , Frederic Pouliot , Luke Lavallee , Alan I. So , Ricardo A. Rendon , Lori Wood , Anil Kapoor , Aly-Khan A. Lalani , Naveen S. Basappa , Bimal Bhindi , Lucas W. Dean , Georg A. Bjarnason , Rodney H. Breau
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 690)
DOI
10.1200/JCO.2023.41.6_suppl.690
Abstract #
690
Poster Bd #
J3
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of age on functional decline following radical nephrectomy: Analysis of the International Marker Consortium for Renal Cancer (INMARC).
First Author: Mimi Vu Nguyen
Poster
2020 Genitourinary Cancers Symposium
Safety and efficacy of immune checkpoint inhibitors (ICI) in metastatic non-clear cell renal cell carcinoma (nccRCC): An institutional experience.
First Author: William Schwartzman
Poster
2018 Genitourinary Cancers Symposium
Activity of third line (3L) therapy in patients with metastatic non-clear-cell renal cell carcinoma (mnccRCC).
First Author: Annalisa Guida
Poster
2016 ASCO Annual Meeting
Transcriptomic profiling of collecting duct carcinoma reveals metabolic and immune aberrations.
First Author: Gabriel G. Malouf